Blog

The latest thoughts from Medicines Law & Policy partners.

Legal tools that lower medicines prices have expanded access to medicines for over two...

LONDON, UK: Millions of people are priced out of access to life-saving medicines. Use of legal tools to reduce prices has been under-reported and...

How not to solve a crisis: The European Commission’s Plan for Transferable Data Exclusivity...

Drug-resistant infections, sometimes called “superbugs,” killed an estimated 1.27 million people in 2019, a number set to rise to 50 million by 2050. It is...

The Waiver that Wasn’t: Is the pharma lobby responsible?

Systemic lobbying pressure from pharmaceutical companies – allegedly attached to threats to withdraw investments – may have been responsible for the watering down of...

Remdesivir developed country price announced

On 29, June 2020 Gilead announced its global price for developed countries for remdesivir, a medicine that has shown some effect in the treatment...

Drug Price Transparency Calls Move from South Africa to World Health Assembly

by Katrina Perehudoff and Jennifer Sellin Over 30 states and 40 business and civil society groups debated strategies for affordable and sustainable medicines prices at...

Are gene-editing therapies patentable? A WIPO side event investigates.

On 6 December, Knowledge Ecology International (KEI) organised an interesting panel on the patentability of new gene- and cell-based medical therapies, as a side...

2018 Round-up of Noteworthy Medicines Law and Policy Events

We are reaching the end of 2018: Time for our end-of-the-year roundup of some significant developments in medicines law and policy. January The Chilean parliament started...

Fair Medicines Pricing requires addressing monopolies and increasing transparency in pharmaceutical markets

The 4th WHO Fair Pricing Forum took place from 6 - 8 February 2024. Ellen 't Hoen spoke at the opening plenary. Below are...

Something is going terribly wrong with the EU Compulsory Licensing Regulation

This week the European Parliament will vote on amendments to the Commission’s proposed regulation of the European Parliament and the Council on compulsory licensing...

The Expanding Reach of the European Patent Office. Good for Health?

The European Patent Office (EPO) is tasked with the examination of patent applications and the granting of patents when these applications meet the patentability...